iSpecimen Inc. (ISPC) stock

ISPCNasdaqServices-Commercial Physical & Biological ResearchFiscal year ends December 31

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 14, 2026Score 7/3028% below fair value

$0.71−0.03 (-3.81%)

Close on Nov 11, 2026Market cap $1.79MP/E –Yield –

iSpecimen gross margin

Gross margin is gross profit as a percentage of revenue.

iSpecimen's gross margin for the twelve months ending Jun 30, 2026 was -98.0%. For fiscal 2025 it was 11.2%, against 45.0% the year before. The highest annual figure on record is 56.2% in fiscal 2020.

Annual gross margin

Period	Period end	Value	Change (pts)
FY2025	Dec 31, 2025	11.2%	−33.8
FY2024	Dec 31, 2024	45.0%	−7.0
FY2023	Dec 31, 2023	51.9%	−2.3
FY2022	Dec 31, 2022	54.3%	+1.4
FY2021	Dec 31, 2021	52.9%	−3.3
FY2020	Dec 31, 2020	56.2%	–

Quarterly gross margin

Change is against the same quarter a year earlier.

Period	Period end	Value	Change (pts)
Q2 FY2026	Jun 30, 2026	45.2%	+7.5
Q1 FY2026	Mar 31, 2026	45.9%	+8.0
Q4 FY2025	Dec 31, 2025	-964.4%	−977.9
Q3 FY2025	Sep 30, 2025	-91.9%	−133.6
Q2 FY2025	Jun 30, 2025	37.7%	−12.5
Q1 FY2025	Mar 31, 2025	37.8%	−20.6
Q4 FY2024	Dec 31, 2024	13.5%	−33.0
Q3 FY2024	Sep 30, 2024	41.6%	−8.3
Q2 FY2024	Jun 30, 2024	50.3%	+2.8
Q1 FY2024	Mar 31, 2024	58.4%	−2.7
Q4 FY2023	Dec 31, 2023	46.5%	−5.9
Q3 FY2023	Sep 30, 2023	49.9%	−4.4
Q2 FY2023	Jun 30, 2023	47.5%	−9.8
Q1 FY2023	Mar 31, 2023	61.1%	+7.4
Q4 FY2022	Dec 31, 2022	52.4%	+0.4
Q3 FY2022	Sep 30, 2022	54.3%	−12.1
Q2 FY2022	Jun 30, 2022	57.3%	+8.5
Q1 FY2022	Mar 31, 2022	53.7%	+8.5
Q4 FY2021	Dec 31, 2021	52.0%	+9.2
Q3 FY2021	Sep 30, 2021	66.4%	+6.6
Q2 FY2021	Jun 30, 2021	48.7%	−19.8
Q1 FY2021	Mar 31, 2021	45.2%	–
Q4 FY2020	Dec 31, 2020	42.8%	–
Q3 FY2020	Sep 30, 2020	59.8%	–
Q2 FY2020	Jun 30, 2020	68.5%	–